Saksenaea vasiformis infection, French Guiana.
A nonimmunocompromised 47-year-old woman with a long history of non-type 1 diabetes mellitus, who had lived in French Guiana for many years, was admitted to Cayenne Hospital on November 18, 2005, with a cutaneous lesion of the abdominal wall and a fever that had lasted for 5 days before she was hospitalized. A skin biopsy specimen was obtained, and the first surgical debridement was performed on day 4 of hospitalization. A diagnosis of zygomycosis was made after direct examination and histopathologic examination of the tissue samples. Treatment was initiated on day 8, beginning with liposomal amphotericin B and itraconazole for 10 days, followed by liposomal amphotericin B alone for 12 days. Persistence of necrotic tissues at the infection site required additional surgical debridement on day 10. Histopathologic examination of the resected tissues showed damaged hyphae of zygomycetes. Resolution of clinical signs was excellent. Additional biopsy specimens taken by the end of treatment on day 21 were negative for fungi by direct examination and culture. Finally, a cicatrix was formed.
Histologic examination of the initial excised tissues showed a localized periumbilical cutaneous lesion of 14 cm x 13 cm. The skin was covered by a 1-mm layer of necrosis. The necrosis extended into all the abdominal adipose tissue at the rectus abdominis muscle and linea alba. Microscopy examination showed extensive superficial mycotic proliferation, with wide and irregular ribbonlike nonseptate hyphae and right-angle branching. These hyphae extended toward the hypodermic fat tissues and were associated with a break in the cell membrane of adipocytes and with crystals inside the adipocytes. These lesions were associated with massive nonsuppurative vascular thrombosis.
Culture of tissues samples on Sabouraud-chloramphenicol-gentamicin agar after 4 days at 30[degrees]C and 37[degrees]C grew a white aerial mold, which covered the entire surface of the agar. Examination by microscopy showed nonseptate sterile hyphae typical of a zygomycete. The fungal isolate was sent to the National Reference Center for Mycology and Antifungals at the Institut Pasteur, Paris. Subcultures on different media including malt extract agar and potato dextrose agar grew sterile mycelia. The isolates were then cultured in nutritionally deficient medium consisting of sterile distilled water supplemented with 0.05% filter-sterilized yeast extract (Difco, Becton, Dickinson and Company, Sparks, MD, USA) solution for 7 days at 37[degrees]C (2). Typical flask-shaped sporangia enabled identification of S. vasiformis (Figure). Sporulation also occurred on Czapek agar after 7 days' incubation at 37[degrees]C.
Molecular identification based on PCR amplification and sequencing of rDNA internal transcribed spacer (ITS) regions was also performed. Briefly, mycelia were grown in liquid Roswell Park Memorial Institute medium, and DNA was extracted as previously described (3). Ribosomal DNA, including the complete ITS1-5.8S-ITS2 region, was amplified with the fungal universal primer pairs V9D/LS266 (4) and ITS1/ITS4 (5), and both strands of PCR products were sequenced. The sequence has been deposited in GenBank (accession no. EU 182902). Sequence alignment with the only S. vasiformis ITS sequence available in the GenBank database showed 82% similarity over 530 bp. This low degree of sequence homology is probably reflective of the need for further phylogenetic study of this genus.
Sporulation on Czapek agar enabled preparation of a sporangiospore suspension used for antifungal susceptibility testing. Sporangiospore suspension was counted microscopically and adjusted to the required density. MICs, determined by the EUCAST reference microdilution method (6), after 48 h of incubation were >8, 2, >8, 0.5, and >8 [micro]g/mL for amphotericin B, itraconazole, voriconazole, posaconazole, and caspofungin, respectively. The MIC of 0.5 [micro]g/mL for posaconazole suggests the potential clinical utility of this agent.
S. vasiformis has been isolated from soil samples in different parts of the world (7). This fungus has been rarely responsible for human infections. A recent review (8), which did not include infrequently cited articles (9,10), found only 30 human cases. This scarcity may occur because the diagnosis is often based on histologic features and S. vasiformis does not sporulate in routine mycology media.
Due to zygomycetes' lack of susceptibility to most of the antifungal agents, identification of a zygomycete as the etiologic agent of an infection is essential for rapid and accurate management of the disease. Rare Zygomycetes species such as S. vasiformis or Apophysomyces elegans should be suspected when a nonsporulating zygomycete is isolated from an infected lesion. When this acute infection is suspected after examination of tissue by microscopy, the fungi should be cultured in specific culture media to induce sporulation or they should be identified by molecular tools.
(1.) Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical rewiew of the etiology of zygomycosis. Mycologia. 1976;68:52-52.
(2.) Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol. 1988;26:1861-3.
(3.) Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, et al. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol. 2006;44:340-9.
(4.) Gerrits van den Ende AG, de Hoog GS. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol. 1999;43:151-62.
(5.) White T J, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MS, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. New York: Academic Press; 1990. p. 315-22.
(6.) Rodriguez-Tudela JL, Barchiesi F, Bille J, Chryssanthou E, Cuenca-Estrella M, Denning D, et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect. 2003;9: i-viii. [cited 2008 Jan 3]. Available from http://www.blackwell-synergy.com/doi/ abs/10.1046/j.1469-0691.2003.00789.x
(7.) Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236-301.
(8.) Vega W, Orellana M, Zaror L, Gene J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006; 162:289-94.
(9.) Gomez Merino E, Blanch Sancho JJ, Iniguez de Onzono L, Terrancle Juan I, Mateos Rodriguez F, Solera Santos J, et al. Necrotic lesion in scalp after injury [in Spanish]. Rev Clin Esp. 2003;203:451-2.
(10.) Upton A, Gabriel R, la Fougere C, Rogers K. A patient with cutaneous zygomycosis due to Saksenaea vasiformis. Infect Dis Clin Pract. 2002;11:137-9.
Address for correspondence: Denis Blanchet, Laboratoire Hospitalier Universitaire de Parasitologie et Mycologie, Centre Hospitalier Andree Rosemon, BP 6006, 97306 Cayenne, French Guiana; email: email@example.com
Denis Blanchet, * Eric Dannaoui, ([dagger]))[double dagger]) Angela Fior, * Florence Huber, * Pierre Couppie, * Nour Salhab, * Damien Hoinard, ([dagger]) and Christine Aznar *
* Centre Hospitalier Andree Rosemon, Cayenne, French Guiana; ([dagger]) lnstitut Pasteur, Paris, France; and ([double dagger]) Universite Paris Descartes, Paris, France
|Printer friendly Cite/link Email Feedback|
|Author:||Blanchet, Denis; Dannaoui, Eric; Fior, Angela; Huber, Florence; Couppie, Pierre; Salhab, Nour; Hoina|
|Publication:||Emerging Infectious Diseases|
|Article Type:||Letter to the editor|
|Date:||Feb 1, 2008|
|Previous Article:||Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom.|
|Next Article:||Q fever in young children, Ghana.|